1 line
37 KiB
Plaintext
1 line
37 KiB
Plaintext
{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T20:51:20Z","timestamp":1702068680153},"reference-count":97,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T00:00:00Z","timestamp":1678492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Despite an improvement in pharmacological therapies and mechanical reperfusion, the outcome of patients with acute myocardial infarction (AMI) is still suboptimal, especially in patients with cardiogenic shock (CS). The incidence of CS accounts for 3\u201315% of AMI cases, with mortality rates of 40% to 50%. In contrast to a large number of trials conducted in patients with AMI without CS, there is limited evidence-based scientific knowledge in the CS setting. Therefore, recommendations and actual treatments are often based on registry data. Similarly, knowledge of the available options in terms of temporary mechanical circulatory support (MCS) devices is not equally widespread, leading to an underutilisation or even overutilisation in different regions\/countries of these treatment options and nonuniformity in the management of CS. The aim of this article is to provide a critical overview of the available literature on the management of CS as a complication of AMI, summarising the most recent evidence on revascularisation strategies, pharmacological treatments and MCS use.<\/jats:p>","DOI":"10.3390\/jcm12062184","type":"journal-article","created":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T07:03:57Z","timestamp":1678691037000},"page":"2184","source":"Crossref","is-referenced-by-count":0,"title":["Contemporary Management of Cardiogenic Shock Complicating Acute Myocardial Infarction"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"http:\/\/orcid.org\/0000-0002-8552-1272","authenticated-orcid":false,"given":"Leonardo","family":"De Luca","sequence":"first","affiliation":[{"name":"Department of Cardio-Thoracic and Vascular Medicine and Surgery, Division of Cardiology, A.O. San Camillo-Forlanini, 00152 Rome, Italy"},{"name":"Faculty of Medicine and Dentistry, UniCamillus-Saint Camillus International University of Health Sciences, 00131 Rome, Italy"}]},{"given":"Raffaella","family":"Mistrulli","sequence":"additional","affiliation":[{"name":"Department of Cardio-Thoracic and Vascular Medicine and Surgery, Division of Cardiology, A.O. San Camillo-Forlanini, 00152 Rome, Italy"}]},{"given":"Riccardo","family":"Scirpa","sequence":"additional","affiliation":[{"name":"Department of Cardio-Thoracic and Vascular Medicine and Surgery, Division of Cardiology, A.O. San Camillo-Forlanini, 00152 Rome, Italy"}]},{"ORCID":"http:\/\/orcid.org\/0000-0002-0169-998X","authenticated-orcid":false,"given":"Holger","family":"Thiele","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Heart Center Leipzig, University of Leipzig, 04289 Leipzig, Germany"}]},{"given":"Giuseppe","family":"De Luca","sequence":"additional","affiliation":[{"name":"Division of Cardiology, AOU \u201cPoliclinico G. Martino\u201d, Department of Clinical and Experimental Medicine, University of Messina, 98166 Messina, Italy"},{"name":"Division of Cardiology, IRCCS Hospital Galeazzi-Sant\u2019Ambrogio, 20161 Milan, Italy"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,11]]},"reference":[{"key":"ref_1","first-page":"e232","article-title":"Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association","volume":"136","author":"Katz","year":"2017","journal-title":"Circulation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jacc.2005.11.018","article-title":"Relationship between patient\u2019s risk profile and benefits in mortality from ad-junctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: A meta-regression analysis of randomized trials","volume":"47","author":"Suryapranata","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ijcard.2011.11.102","article-title":"A meta-analytic overview of thrombectomy during primary angioplasty","volume":"166","author":"Navarese","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijcard.2017.06.022","article-title":"Drug-Eluting Stent in Primary Angioplasty (DESERT 3) cooperation. Everolimus eluting stent vs. first generation drug-eluting stent in primary angioplasty: A pooled patient-level meta-analysis of randomized trials","volume":"244","author":"Smits","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1093\/eurheartj\/ehz363","article-title":"Management of cardiogenic shock complicating myocardial infarction: An update 2019","volume":"40","author":"Thiele","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/ejhf.1769","article-title":"Composite trends of cardiogenic shock complicating acute myocardialinfarction","volume":"22","author":"Savonitto","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1093\/eurheartj\/ehs264","article-title":"Improvedoutcome of cardiogenic shock at the acute stage of myocardial infarction: A report from the USIK 1995, USIC 2000, and FAST-MI French nationwideregistries","volume":"33","author":"Aissaoui","year":"2012","journal-title":"Eur. Heart J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/2048872619894254","article-title":"Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardialinfarctioncomplicated by cardiogenic shock: A document of the Acute Cardio-vascular Care Association of the European Society of Cardiology","volume":"9","author":"Zeymer","year":"2020","journal-title":"Eur. Heart J. Acute Cardiovasc. Care."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0002-9149(02)03115-6","article-title":"Outcome in patients treated with primary angioplasty for acute myocardial infarction due to left main coronary artery occlusion","volume":"91","author":"Suryapranata","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2459\/JCM.0b013e328304ae7f","article-title":"BLITZ Investigators.Cardiogenic shock developing in the coronary care unit in pa-tients with ST-elevation myocardial infarction","volume":"9","author":"Savonitto","year":"2008","journal-title":"J. Cardiovasc. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1161\/01.CIR.0000120504.31457.28","article-title":"Impaired myocardial perfusion is a major explanation of the poor outcome observed in patients undergoing primary angioplasty for ST-segment-elevation myocardial infarction and signs of heart failure","volume":"109","author":"Hoorntje","year":"2004","journal-title":"Circulation"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ahj.2009.06.029","article-title":"EGYPT Cooperation. Association between advanced Killip class at presentation and impaired myocardial perfusion among patients with ST-segment elevation myocardial infarction treated with primary angioplasty and adjunctive glycoprotein IIb-IIIa inhibitors","volume":"158","author":"Gibson","year":"2009","journal-title":"Am. Heart J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1001\/jama.2021.18323","article-title":"Cardiogenic Shock After Acute Myocardial Infarction","volume":"326","author":"Samsky","year":"2021","journal-title":"JAMA"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Vincent, J.-L., e Silva, A.Q., Couto, L., and Taccone, F.S. (2016). The value of blood lactate kinetics in critically ill patients: A systematic review. Crit. Care, 20.","DOI":"10.1186\/s13054-016-1403-5"},{"key":"ref_15","unstructured":"Vasan, R.S., and Sawyer, D.B. (2018). Encyclopedia of Cardiovascular Researchand Medicine, Elsevier."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/j.amjcard.2018.08.065","article-title":"Temporal Trends in Utilization of Right-Sided Heart Catheterization Among Percutaneous Ventricular Assist Device Recipients in Acute Myocardial Infarction Complicated by Cardiogenic Shock","volume":"122","author":"Nalluri","year":"2018","journal-title":"Am. J. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/ccd.27427","article-title":"Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: The Detroit cardiogenic shock initiative","volume":"91","author":"Basir","year":"2017","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1001\/jama.294.13.1625","article-title":"Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness","volume":"294","author":"Binanay","year":"2005","journal-title":"JAMA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ccd.28329","article-title":"SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019","volume":"94","author":"Baran","year":"2019","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.jacc.2019.07.077","article-title":"Cardiogenic Shock Classification to Predict Mortality in the Cardiac Intensive Care Unit","volume":"74","author":"Jentzer","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jacc.2022.01.018","article-title":"SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) As-sociation for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021","volume":"79","author":"Naidu","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2017.02.027","article-title":"Risk Stratification for Patients in Cardiogenic Shock After Acute Myocardial Infarction","volume":"69","author":"Fuernau","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1093\/eurheartj\/ehab110","article-title":"The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction","volume":"42","author":"Ceglarek","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","article-title":"PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock","volume":"377","author":"Thiele","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1093\/eurheartj\/ehy127","article-title":"Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: The ORBI risk score","volume":"39","author":"Auffret","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4244\/EIJY14M09_10","article-title":"Intra-aortic balloon counterpulsation reduces mortality in large anterior myocardial infarction complicated by persistent ischaemia: A CRISP-AMI substudy","volume":"11","author":"Veer","year":"2015","journal-title":"Eurointervention"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1097\/CCM.0b013e31816f7cf7","article-title":"Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock","volume":"36","author":"Combes","year":"2008","journal-title":"Crit. Care Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1093\/eurheartj\/ehv194","article-title":"Predicting survival after ECMO for refractory cardiogenic shock: The survival after veno-arterial-ECMO (SAVE)-score","volume":"36","author":"Schmidt","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1161\/CIRCULATIONAHA.108.814947","article-title":"Thirty-year trends (1975 to 2005) in the magnitude of, manage-ment of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: A population-based perspective","volume":"119","author":"Goldberg","year":"2009","journal-title":"Circulation"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Nguyen, H.L., Yarzebski, J., Lessard, D., Gore, J.M., McManus, D.D., and Goldberg, R.J. (2017). Ten-Year (2001\u20132011) Trends in the Incidence Rates and Short-Term Outcomes of Early Versus Late Onset Cardiogenic Shock After Hospitalization for Acute Myocardial Infarction. J. Am. Heart Assoc., 6.","DOI":"10.1161\/JAHA.117.005566"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jacc.2015.11.048","article-title":"Post-Hospital Outcomes of Patients With Acute Myocardial Infarction With Cardiogenic Shock","volume":"67","author":"Shah","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e815","DOI":"10.1161\/CIR.0000000000000959","article-title":"Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart Association","volume":"143","author":"Henry","year":"2021","journal-title":"Circulation"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199908263410901","article-title":"Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock","volume":"341","author":"Hochman","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jama.285.2.190","article-title":"One-Year Survival Following Early Revascularization for Cardiogenic Shock","volume":"285","author":"Hochman","year":"2001","journal-title":"JAMA"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.295.21.2511","article-title":"Early Revascularization and Long-term Survival in Cardiogenic Shock Complicating Acute Myocardial Infarction","volume":"295","author":"Hochman","year":"2006","journal-title":"JAMA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJM199110173251601","article-title":"Cardiogenic Shock after Acute Myocardial Infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988","volume":"325","author":"Goldberg","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ejhf.1750","article-title":"Trends in cardiogenic shock complicating acute myocardial infarction","volume":"22","author":"Aissaoui","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/ejhf.339","article-title":"Temporal trends in the epidemiology, management, and outcome of patients with cardiogenic shock complicating acute coronary syndromes","volume":"17","author":"Olivari","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_42","first-page":"1824","article-title":"Delays in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction Patients Presenting With Cardiogenic Shock","volume":"11","author":"Kochar","year":"2018","journal-title":"JACC: Cardiovasc. Interv."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0735-1097(03)01051-9","article-title":"Correlates of one-year survival inpatients with cardiogenic shock complicating acute myocardial infarction: Angiographic findings from the SHOCK trial","volume":"42","author":"Sanborn","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"TRIUMPH Investigators, Alexander, J.H., Reynolds, H.R., Stebbins, A.L., Dzavik, V., Harrington, R.A., Van de Werf, F., and Hochman, J.S. (2007). Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: The TRIUMPH randomized controlled trial. JAMA, 297, 1657\u20131666.","DOI":"10.1001\/jama.297.15.joc70035"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ahj.2009.10.035","article-title":"Percutaneous coronary intervention or coronary artery bypass surgery for cardiogenic shock and multivessel coronary artery disease?","volume":"159","author":"Mehta","year":"2010","journal-title":"Am. Heart J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1056\/NEJMoa1808788","article-title":"One-Year Outcomes after PCI Strategies in Cardiogenic Shock","volume":"379","author":"Thiele","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Lee, J.M., Rhee, T., Kim, H.K., Hwang, D., Lee, S.H., Choi, K.H., Kim, J., Park, T.K., Yang, J.H., and Bin Song, Y. (2019). Comparison of Long-Term Clinical Outcome Between Multivessel Percutaneous Coronary Intervention Versus Infarct-Related Artery\u2013Only Revascularization for Patients With ST-Segment\u2013Elevation Myocardial Infarction With Cardiogenic Shock. J. Am. Heart Assoc., 8.","DOI":"10.1161\/JAHA.119.013870"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.ahj.2010.10.012","article-title":"Evaluation and management of special subgroups after primary percutaneous coronary intervention","volume":"160","author":"Tomai","year":"2010","journal-title":"Am. Heart J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur. J. Heart-Fail."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure [published correction appears in EurHeart J","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Unverzagt, S., Wachsmuth, L., Hirsch, K., Thiele, H., Buerke, M., Haerting, J., Werdan, K., and Prondzinsky, R. (2014). Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome. Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD009669.pub2"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1093\/eurheartj\/ehy600","article-title":"Treatments targeting inotropy","volume":"40","author":"Maack","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"Biston","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2018.04.051","article-title":"Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction","volume":"72","author":"Levy","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/eurheartj\/ehi875","article-title":"Evidence-based use of levosimendan in different clinical settings","volume":"27","author":"Colucci","year":"2006","journal-title":"Eur. Heart J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s13054-016-1387-1","article-title":"Current real-life use of vasopressors and inotropes in cardiogenic shock\u2014Adrenaline use is associated with excess organ injury and mortality","volume":"20","author":"Lassus","year":"2016","journal-title":"Crit. Care."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1046\/j.1399-6576.2003.00252.x","article-title":"Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines","volume":"47","author":"Buberl","year":"2003","journal-title":"Acta Anaesthesiol. Scand."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0735-1097(02)02968-6","article-title":"Heart failure etiology and response to milrinone in decompensated heart failure: Results from the OPTIME-CHF study","volume":"41","author":"Felker","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2008.02.083","article-title":"Sodium Nitroprusside for Advanced Low-Output Heart Failure","volume":"52","author":"Mullens","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCULATIONAHA.117.032722","article-title":"Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction","volume":"139","author":"Fuernau","year":"2019","journal-title":"Circulation"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/jama.2021.24776","article-title":"HYPO-ECMO Trial Group and the International ECMO Network (ECMONet).Effect of Moderate Hypothermia vs. Nor-mothermia on 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane Oxygenation: A Randomized Clinical Trial","volume":"327","author":"Levy","year":"2022","journal-title":"JAMA"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jacc.2014.07.958","article-title":"National Trends in the Utilization of Short-Term Mechanical Circulatory Support","volume":"64","author":"Stretch","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/ccd.29834","article-title":"Outcomes of mechanical circulatory support for acute myo-cardial infarction complicated by cardiogenic shock","volume":"99","author":"Kim","year":"2022","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/SHK.0b013e31824a67af","article-title":"Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute my-ocardial infarction complicated by cardiogenic shock: The prospective, randomized IABP shock trial","volume":"37","author":"Prondzinsky","year":"2012","journal-title":"Shock"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0735-1097(00)00875-5","article-title":"Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: A report from the SHOCK Trial Registry. Should we emergently revascularize Occluded Coronaries for cardiogenicshock?","volume":"36","author":"Sanborn","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1067\/mhj.2001.115295","article-title":"The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: Data from the National Registry of Myocardial Infarction 2","volume":"141","author":"Barron","year":"2001","journal-title":"Am. Heart J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(13)61783-3","article-title":"Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): Final 12 month results of a randomised, open-label trial","volume":"382","author":"Thiele","year":"2013","journal-title":"Lancet"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1161\/CIRCULATIONAHA.118.038201","article-title":"Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute Myocardial Infarction: Long-Term 6-Year Outcome of the Randomized IABP-SHOCK II Trial","volume":"139","author":"Thiele","year":"2019","journal-title":"Circulation"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.jacc.2008.05.065","article-title":"A randomizedclinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus in-tra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction","volume":"52","author":"Seyfarth","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jacc.2016.10.022","article-title":"Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction","volume":"69","author":"Ouweneel","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1093\/eurheartj\/ehx363","article-title":"Percutaneous short-term active mechanical support devices in cardiogenic shock: A systematic review and collaborative meta-analysis of randomized trials","volume":"38","author":"Thiele","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.118.036614","article-title":"ImpellaSupport for Acute Myocardial Infarction Complicated by Cardiogenic Shock","volume":"139","author":"Schrage","year":"2019","journal-title":"Circulation"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/CIRCULATIONAHA.119.044007","article-title":"The Evolving Landscape of Impella Use in the United States Among Patients Undergo-ing Percutaneous Coronary Intervention With Mechanical Circulatory Support","volume":"141","author":"Amin","year":"2020","journal-title":"Circulation"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Miller, P.E., Bromfield, S.G., Ma, Q., Crawford, G., Whitney, J., DeVries, A., and Desai, N.R. (2022). Clinical Outcomes and Cost Associated With an Intravascular Microaxial Left Ventricular Assist Device vs. Intra-aortic Balloon Pump in Patients Presenting With Acute Myocardial Infarction Complicated by Cardiogenic Shock. JAMA Intern. Med., 182.","DOI":"10.1001\/jamainternmed.2022.2735"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Dhruva, S.S., Ross, J.S., Mortazavi, B.J., Hurley, N.C., Krumholz, H.M., Curtis, J.P., Berkowitz, A.P., Masoudi, F.A., Messenger, J.C., and Parzynski, C.S. (2021). Use of Mechanical Circulatory Support Devices Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock. JAMA Netw. Open, 4.","DOI":"10.1001\/jamanetworkopen.2020.37748"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ahj.2022.10.078","article-title":"Danish-German cardiogenic shock trial-DanGer shock: Trial design update","volume":"255","author":"Gerke","year":"2023","journal-title":"Am. Heart J."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.healun.2015.08.018","article-title":"Benefits of a novelpercutaneousventricular assist device for right heart failure: The prospective RECOVER RIGHT study of the Impella RP device","volume":"34","author":"Anderson","year":"2015","journal-title":"J. Heart Lung Transplant."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Briceno, N., Annamalai, S.K., Reyelt, L., Crowley, P., Qiao, X., Swain, L., Pedicini, R., Foroutanjazi, S., Jorde, L., and Yesodharan, G. (2019). Left Ventricular Unloading Increases the Coronary Collateral Flow Index Before Reperfusion and Reduces Infarct Size in a Swine Model of Acute Myocardial Infarction. J. Am. Heart Assoc., 8.","DOI":"10.1161\/JAHA.119.013586"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCULATIONAHA.118.038269","article-title":"Unloading the Left Ventricle Before Reperfusion in Patients With Anterior ST-Segment\u2013Elevation Myocardial Infarction","volume":"139","author":"Kapur","year":"2019","journal-title":"Circulation"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ahj.2022.08.011","article-title":"Primary left ventricular unloading with delayed reperfusion in patients with anterior ST-elevation myocardial infarc-tion: Rationale and design of the STEMI-DTU randomized pivotal trial","volume":"254","author":"Kapur","year":"2022","journal-title":"Am. Heart J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1161\/CIRCULATIONAHA.118.036691","article-title":"Venoarterial Extracorporeal Membrane Oxygenation for Cardiopulmonary Support","volume":"138","author":"Becher","year":"2018","journal-title":"Circulation"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jacc.2018.11.038","article-title":"Venoarterial ECMO for Adults","volume":"73","author":"Guglin","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ejhf.850","article-title":"Modalities and Effects of Left Ventricle Unloading on Extracorporeal Life support: A Review of the Current Literature","volume":"19","author":"Meani","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jacc.2018.10.085","article-title":"Left Ventricular Unloading During Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock","volume":"73","author":"Russo","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0140-6736(08)60958-7","article-title":"Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: An observational study and propensity analysis","volume":"372","author":"Chen","year":"2008","journal-title":"Lancet"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0140-6736(20)32338-2","article-title":"Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): A phase 2, single centre, open-label, randomised controlled trial","volume":"396","author":"Yannopoulos","year":"2020","journal-title":"Lancet"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2022.1025","article-title":"Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial","volume":"327","author":"Belohlavek","year":"2022","journal-title":"JAMA"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s10741-021-10088-8","article-title":"Contemporary device management of cardiogenic shock following acute myocardial infarction","volume":"27","author":"Suleiman","year":"2021","journal-title":"Heart Fail. Rev."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/CIRCULATIONAHA.122.062949","article-title":"Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Results of the ECMO-CS Randomized Clinical Trial","volume":"147","author":"Ostadal","year":"2023","journal-title":"Circulation"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.jacc.2019.02.044","article-title":"Extracorporeal Life Support in Cardiogenic Shock Complicating Acute Myocardial Infarction","volume":"73","author":"Brunner","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1007\/s00134-016-4536-8","article-title":"Extracorporeal life support during cardiac arrest and cardiogenic shock: A systematic review and meta-analysis","volume":"42","author":"Ouweneel","year":"2016","journal-title":"Intensiv. Care Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e1173","DOI":"10.1097\/CCM.0000000000002692","article-title":"Extracorporeal Circulatory Support in Acute Coronary Syndromes","volume":"45","author":"Pavasini","year":"2017","journal-title":"Crit. Care Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.athoracsur.2013.09.008","article-title":"Complications of Extracorporeal Membrane Oxygenation for Treatment of Cardiogenic Shock and Cardiac Arrest: A Meta-Analysis of 1866 Adult Patients","volume":"97","author":"Cheng","year":"2014","journal-title":"Ann. Thorac. Surg."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e1227","DOI":"10.4244\/EIJ-D-20-01076","article-title":"Veno-arterial extracorporeal membrane oxygenation (ECMO) in patients with cardiogenic shock: Rationale and design of the randomised, multicentre, open-label EURO SHOCK trial","volume":"16","author":"Banning","year":"2021","journal-title":"Eurointervention"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/ehjacc\/zuac124","article-title":"What to expect from upcoming MCS randomized trials?","volume":"11","author":"Zeymer","year":"2022","journal-title":"Eur. Heart J. Acute. Cardiovasc. Care"},{"key":"ref_96","unstructured":"(2023, February 05). Assessment of ECMO in Acute Myocardial Infarction Cardiogenic Shock (ANCHOR), Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04184635."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2021.01.002","article-title":"Extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock\u2014Design and rationale of the ECLS-SHOCK trial","volume":"234","author":"Thiele","year":"2021","journal-title":"Am. Heart J."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/6\/2184\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T20:21:43Z","timestamp":1702066903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/6\/2184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,11]]},"references-count":97,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["jcm12062184"],"URL":"http:\/\/dx.doi.org\/10.3390\/jcm12062184","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":["General Medicine"],"published":{"date-parts":[[2023,3,11]]}}} |